Showing papers by "Hannu Vanhanen published in 2006"
TL;DR: It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid- Lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol.
Abstract: Objectives. The most important risk factors for coronary heart disease are hypercholesterolemia, smoking and hypertension. To find out which one – lowering cholesterol concentration or using antihy...
6 citations